Other names: ADT
Categories: Prescription Medication
Description:
Androgen Deprivation Therapy (ADT) is the foundational treatment for metastatic hormone-sensitive prostate cancer (mHSPC). It works by suppressing testosterone production, which slows or stops the growth of prostate cancer cells that still depend on androgens.
In mHSPC, ADT is almost always combined with additional systemic therapy to improve survival. These combinations include:
-ADT + Docetaxel chemotherapy (especially for high-volume disease)
-ADT + Abiraterone (with prednisone)
-ADT + Enzalutamide or Apalutamide
The choice of agent and combination depends on disease volume, patient age, comorbidities, and treatment goals. While effective, long-term ADT can cause side effects such as fatigue, hot flashes, sexual dysfunction, and metabolic changes.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the effectiveness of Androgen Deprivation Therapy in treating Metastatic hormone-sensitive prostate cancer. The author has not provided any review or rating for this treatment, making it difficult to draw a conclusion about its efficacy without further data or expert opinion.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
